1Flourish Capital
VC Fund
Mountain View, United States
1Flourish Capital is a VC fund in Mountain View focused on Artificial Intelligence and Software. Faith Driven Venture Firm investing in, and mentoring early-stage – tech enabled startups led by high character – high capacity entrepreneurs who recognize culture is critical to success.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries 1Flourish Capital invests in
Stages 1Flourish Capital invests in
Countries 1Flourish Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Lane
|
|||
4 more contacts available
Investment Focus
Industry
- Artificial Intelligence 5 (25%)
- Software 4 (20%)
- Machine Learning 4 (20%)
- SaaS 3 (15%)
- Analytics 3 (15%)
Stage
- Seed 9 (45%)
- Series A 7 (35%)
- Funding Round 2 (10%)
- Venture - Series Unknown 2 (10%)
Country
- United States 18 (90%)
- Mexico 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David Lane
Partner
|
Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
WeatherPromise
|
WeatherPromise offers weather forecasts. It provides vacation, outdoor events, and outdoor activity reports. | $12.8M / Series A / Jan 13, 2026 | |
Lemurian Labs
|
Lemurian Labs has created a universal platform that works across any hardware and spans compiler technology and runtime orchestration. This streamlined, hardware-agnostic approach simplifies AI development, enabling organizations to write code once and deploy it seamlessly across edge, cloud and on-premise environments. By cutting through thecomplexity of fragmented software ecosystems, Lemurian Labs empowers businesses to build and scale AI efficiently, affordably and responsibly—unlocking the full potential of AI innovation without proprietary constraints. | $28M / Series A / Dec 03, 2025 | |
Cascade Biocatalysts
|
Cascade Biocatalysts creates productive enzymes for economical biomanufacturing of sustainable chemicals. | $2.8M / Seed / Sep 09, 2025 | |
Trebellar
|
Trebellar specializes in helping firms optimize building operations and space decisions to reduce carbon emissions. It also helps in providing advice to better outcomes for more efficient use of office space, engaged workforces, less energy waste, or lower emissions. | $3.5M / Seed / Jul 12, 2023 | |
Stakeholder Labs
|
Stakeholder Labs builds enterprise software to help companies measure and increase retail investor engagement. Its flagship product, Roundtable, enables companies to verify shareholders, measure their customer loyalty and offer unique shareholder rewards. To learn more about Stakeholder Labs, please visit stakeholderlabs.com. | $4.2M / Seed / Feb 14, 2023 | |
Caravan
|
Caravan is a community and service dedicated on serving the creator economy and creators with ticketing and access at the events. | Venture - Series Unknown / Jan 01, 2023 | |
CrowdSmart.ai
|
Founded in 2020, CrowdSmart.ai helps organizations make efficient, accurate decisions by combining the best of human and artificial intelligence. CrowdSmart's industry-specific SaaS solutions enable decision makers to collect and refine predictive insights from colleagues, partners, and external experts. | Seed / Sep 01, 2022 | |
Butlr
|
Butlr is an AI people-sensing platform using body heat to detect occupancy, headcount, body posture, and activity, and generate accurate, real-time, and historical spatial insights for healthcare and sustainable buildings. Their sensor technology detects human presence anonymously using low-resolution thermal data and advanced AI and machinelearning. | $22M / Series A / Jul 26, 2022 | |
TuDOC
|
Creating the first and only chain of branded, convenient, state of the art, high quality, primary care/urgent care clinics in Mexico, to capitalize on a large untapped market opportunity and the large gap in the market | Series A / Apr 13, 2022 | |
Melzi Surgical
|
Melzi is a surgical device company dedicated to creating innovative technologies that improve patient outcomes while reducing hospital expenses. The Company’s lead product, the Melzi Sharps Finder, is a U.S. FDA registered device designed to locate instruments, needles, broken pieces and fragments, or sharp objects (“sharps”) that have been lostinside a patient during surgery. | $4M / Series A / Apr 11, 2022 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does 1Flourish Capital invest in?
1Flourish Capital invests primarily in Artificial Intelligence, Software and Machine Learning startups, most often at Seed and Series A stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact 1Flourish Capital?
Public channels for 1Flourish Capital include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 1Flourish Capital?
The team at 1Flourish Capital includes David Lane (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
